biOasis Technologies Ord Shs V.BTI.H

Alternate Symbol(s): BIOAF

Healthcare Biotechnology

Bioasis Technologies Inc. is a Canada-based biopharmaceutical company focused on research and development of technologies and products intended for the treatment of patients with nervous system, including central nervous system, diseases and disorders. The Company is engaged in the development of its xB 3 platform, which is a peptide-based technology, for the transport of therapeutic agents, in particular biological products, across the blood-brain barrier (BBB). It is focused on both orphan drug indications, including brain cancers, and rare genetic neurodegenerative diseases and neuroinflammatory conditions. The Company is also focused on its Epidermal Growth Factor (EGF) platform for treating rare and orphan neurodegenerative and neuroinflammatory disorders. EGF is a protein that stimulates cell growth and differentiation, notably for myelin producing cells. Its development programs include xB3-001: Brain Metastases, xB3-002: Glioblastoma and xB3-007: Neurodegenerative Disease.

TSXV:BTI.H - Post by User

biOasis Technologies Ord Shs

Bullboard Posts

Comment by KayakerBCon Feb 10, 2016 7:16pm

74 Views

Post# 24545681

RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:Anybody know...?

SirDigiPumperDumper, I'm still waiting for you to explain why BTI should "promote that new delivery technology".

You know the one I'm talking about right? The one that doesn't yet exist and may never exist. Why should BTI be promoting it?

But why stop there. Do you think BTI should promote the cure for all diseases? And how about instant pizza delivery through a worm hole? That would be a good promotion.

Harvard? You want to know about Harvard? Why not just wait a few weeks until you load up on BTI again. Then, not only can you explain it yourself, but you can pump the daylights out of it!!!

Bullboard Posts

WINNERS of the COP 29: Siemens Energy, Plug Power, dynaCERT!